{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:05:03Z","timestamp":1786460703878,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Startup Fund for Scientific Research at Fujian Medical University","award":["2022QH1126"],"award-info":[{"award-number":["2022QH1126"]}]},{"name":"the Natural Science Foundation of Fujian Province","award":["2025J01822"],"award-info":[{"award-number":["2025J01822"]}]},{"name":"the Institute Internal Matching Funds for PhD Training","award":["2024BD0802"],"award-info":[{"award-number":["2024BD0802"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 1 diabetes mellitus (T1DM) is a chronic metabolic disorder characterized by the autoimmune destruction of insulin-producing \u03b2-cells in the pancreas, leading to absolute insulin deficiency and persistent hyperglycemia. The immune system plays a pivotal role in the development of T1DM, with dendritic cells (DCs) acting as crucial modulators of immune responses. Despite this, the specific role of ADAM19 within the T1DM immune microenvironment remains poorly understood, particularly its expression in DCs and potential effects on pancreatic \u03b2-cell function. Further research is needed to explore these aspects in peripheral blood mononuclear cells (PBMCs) and pancreatic tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to investigate the association between ADAM19 expression in DCs and immune features in T1DM. Among the genes consistently upregulated across four independent PBMC transcriptomic datasets and previously implicated in immune regulation, ADAM19 exhibited the most pronounced differential expression in dendritic cell subsets. We therefore focused on ADAM19 to determine whether it influences DC function, thereby disrupting the immune microenvironment and exacerbating pancreatic \u03b2-cell damage. Additionally, the study evaluates the potential of ADAM19 as a candidate biomarker for T1DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study analyzed public bulk RNA-seq data from peripheral blood mononuclear cells (PBMCs) derived from three datasets (GSE156035, GSE55100, GSE9006), comprising a total of 129 samples (75 T1DM patients and 54 healthy controls). For discovery, an additional in-house PBMC RNA-seq cohort of 20 samples (13 T1DM, 7 controls) was included. Single-cell RNA-seq (scRNA-seq) data were obtained from PBMCs and pancreatic islets, comprising a total of 117 samples (55 from T1DM patients and 62 from healthy controls), with detailed distributions including 46 T1DM and 31 controls from PBMCs, and 9 T1DM and 31 controls from pancreas samples. By integrating transcriptomic and single-cell data, we evaluated the expression patterns of ADAM19 in DCs from T1DM patients. Analytical approaches included partial least squares discriminant analysis (PLS-DA), differential expression analysis (DEG), Gene Set Enrichment Analysis (GSEA), pseudotime trajectory analysis, and cell\u2013cell communication inference to explore the potential involvement of ADAM19 in immune responses. For validation, an independent in-house cohort of PBMC samples (44 samples: 29 T1DM, 15 controls) was examined using RT-qPCR to assess the correlation between ADAM19 expression and C-peptide levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ADAM19 expression was consistently elevated in PBMCs of T1DM patients across all datasets, with the highest levels observed in DCs in single-cell RNA-seq data. Receiver operating characteristic (ROC) analysis demonstrated AUC values greater than 0.7 in all cohorts, reaching 0.93 in the in-house dataset. Elevated ADAM19 expression in DCs was associated with altered immune cell proportions and reduced fasting C-peptide levels in T1DM patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identifies an association between elevated ADAM19 expression in DCs and T1DM immune features, suggesting potential links to immune dysregulation and \u03b2-cell dysfunction. ADAM19 shows promise as a candidate biomarker, warranting further validation for diagnostic and therapeutic applications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13098-026-02170-8","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T18:45:37Z","timestamp":1780685137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Upregulation of ADAM19 in dendritic cells is associated with immune features and lower C-peptide levels in type 1 diabetes mellitus"],"prefix":"10.1186","volume":"18","author":[{"given":"Lijun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjian","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanrong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengrong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6487-7029","authenticated-orcid":false,"given":"Huibin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"2","key":"2170_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1503\/cmaj.060244","volume":"175","author":"KM Gillespie","year":"2006","unstructured":"Gillespie KM. Type 1 diabetes: pathogenesis and prevention. CMAJ. 2006;175(2):165\u201370.","journal-title":"CMAJ"},{"issue":"3","key":"2170_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jdiacomp.2014.12.014","volume":"29","author":"LM Jaacks","year":"2015","unstructured":"Jaacks LM, et al. Dietary patterns associated with HbA1c and LDL cholesterol among individuals with type 1 diabetes in China. J Diabetes Complications. 2015;29(3):343\u20139.","journal-title":"J Diabetes Complications"},{"key":"2170_CR3","doi-asserted-by":"publisher","first-page":"977413","DOI":"10.3389\/fimmu.2022.977413","volume":"13","author":"J Qiu","year":"2022","unstructured":"Qiu J, et al. Latent autoimmune diabetes in adults in China. Front Immunol. 2022;13:977413.","journal-title":"Front Immunol"},{"key":"2170_CR4","doi-asserted-by":"crossref","unstructured":"Patterson P C.C., et al. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:p107842.","DOI":"10.1016\/j.diabres.2019.107842"},{"issue":"2","key":"2170_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri M, et al. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020;10(2):98\u2013115.","journal-title":"Health Promot Perspect"},{"issue":"20","key":"2170_CR6","doi-asserted-by":"publisher","first-page":"eaao4013","DOI":"10.1126\/sciimmunol.aao4013","volume":"3","author":"S Culina","year":"2018","unstructured":"Culina S, et al. Islet-reactive CD8(+) T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci Immunol. 2018;3(20):eaao4013.","journal-title":"Sci Immunol"},{"issue":"4","key":"2170_CR7","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/db07-1331","volume":"57","author":"H Erlich","year":"2008","unstructured":"Erlich H, et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes. 2008;57(4):1084\u201392.","journal-title":"Diabetes"},{"issue":"3","key":"2170_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/ijms19030794","volume":"19","author":"V Della Marca","year":"2018","unstructured":"Della Marca V, Gianchecchi E, Fierabracci A. Type 1 Diabetes and Its Multi-Factorial Pathogenesis: The Putative Role of NK Cells. Int J Mol Sci. 2018;19(3):794.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2170_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11892-014-0543-8","volume":"14","author":"RM Hinman","year":"2014","unstructured":"Hinman RM, Cambier JC. Role of B lymphocytes in the pathogenesis of type 1 diabetes. Curr Diab Rep. 2014;14(11):543.","journal-title":"Curr Diab Rep"},{"issue":"6","key":"2170_CR10","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.coi.2013.10.004","volume":"25","author":"S Guerder","year":"2013","unstructured":"Guerder S, et al. Dendritic cells in tolerance and autoimmune diabetes. Curr Opin Immunol. 2013;25(6):670\u20135.","journal-title":"Curr Opin Immunol"},{"key":"2170_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fimmu.2015.00288","volume":"6","author":"JD Price","year":"2015","unstructured":"Price JD, Tarbell KV. The Role of Dendritic Cell Subsets and Innate Immunity in the Pathogenesis of Type 1 Diabetes and Other Autoimmune Diseases. Front Immunol. 2015;6:288.","journal-title":"Front Immunol"},{"issue":"10","key":"2170_CR12","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel RA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964\u201374.","journal-title":"Diabetes Care"},{"issue":"20","key":"2170_CR13","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.2174\/138161209788682352","volume":"15","author":"B Qi","year":"2009","unstructured":"Qi B, Newcomer RG, Sang QX. ADAM19\/adamalysin 19 structure, function, and role as a putative target in tumors and inflammatory diseases. Curr Pharm Des. 2009;15(20):2336\u201348.","journal-title":"Curr Pharm Des"},{"issue":"3","key":"2170_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1006\/bbrc.2000.4200","volume":"280","author":"P Wei","year":"2001","unstructured":"Wei P, et al. Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19\/meltrin beta. Biochem Biophys Res Commun. 2001;280(3):744\u201355.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2170_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1128\/MCB.24.1.96-104.2004","volume":"24","author":"HM Zhou","year":"2004","unstructured":"Zhou HM, et al. Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol. 2004;24(1):96\u2013104.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2170_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00421-005-1333-4","volume":"94","author":"NK LeBrasseur","year":"2005","unstructured":"LeBrasseur NK, et al. The expression of neuregulin and erbB receptors in human skeletal muscle: effects of progressive resistance training. Eur J Appl Physiol. 2005;94(4):371\u20135.","journal-title":"Eur J Appl Physiol"},{"key":"2170_CR17","doi-asserted-by":"publisher","first-page":"p7281986","DOI":"10.1155\/2017\/7281986","volume":"2017","author":"L Weerasekera","year":"2017","unstructured":"Weerasekera L, et al. ADAM19: A Novel Target for Metabolic Syndrome in Humans and Mice. Mediators Inflamm. 2017;2017:p7281986.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"2170_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13073-024-01300-z","volume":"16","author":"MA Honardoost","year":"2024","unstructured":"Honardoost MA, et al. Systematic immune cell dysregulation and molecular subtypes revealed by single-cell RNA-seq of subjects with type 1 diabetes. Genome Med. 2024;16(1):45.","journal-title":"Genome Med"},{"key":"2170_CR19","doi-asserted-by":"publisher","first-page":"1397661","DOI":"10.3389\/fendo.2024.1397661","volume":"15","author":"D Gu","year":"2024","unstructured":"Gu D, et al. Single-cell analysis of human PBMCs in healthy and type 2 diabetes populations: dysregulated immune networks in type 2 diabetes unveiled through single-cell profiling. Front Endocrinol (Lausanne). 2024;15:1397661.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2170_CR20","doi-asserted-by":"publisher","first-page":"e1092","DOI":"10.1002\/ctm2.1092","volume":"12","author":"C Liu","year":"2022","unstructured":"Liu C, et al. Single-cell transcriptomic analysis of PB and BM NK cells from severe aplastic anaemia patients. Clin Transl Med. 2022;12(12):e1092.","journal-title":"Clin Transl Med"},{"issue":"2","key":"2170_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.immuni.2020.07.003","volume":"53","author":"U Cytlak","year":"2020","unstructured":"Cytlak U, et al. Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans. Immunity. 2020;53(2):353\u2013e3708.","journal-title":"Immunity"},{"issue":"1","key":"2170_CR22","doi-asserted-by":"publisher","first-page":"10757","DOI":"10.1038\/s41598-018-28986-7","volume":"8","author":"JCM Schlachetzki","year":"2018","unstructured":"Schlachetzki JCM, et al. A monocyte gene expression signature in the early clinical course of Parkinson\u2019s disease. Sci Rep. 2018;8(1):10757.","journal-title":"Sci Rep"},{"key":"2170_CR23","doi-asserted-by":"publisher","first-page":"117793222311867","DOI":"10.1177\/11779322231186719","volume":"17","author":"M Giriyappagoudar","year":"2023","unstructured":"Giriyappagoudar M, et al. Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Bioinformatics and Next-Generation Sequencing Data Analysis. Bioinform Biol Insights. 2023;17:11779322231186719.","journal-title":"Bioinform Biol Insights"},{"issue":"5","key":"2170_CR24","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.pan.2022.04.015","volume":"22","author":"AM Rygiel","year":"2022","unstructured":"Rygiel AM, et al. Variants in the pancreatic CUB and zona pellucida-like domains 1 (CUZD1) gene in early-onset chronic pancreatitis - A possible new susceptibility gene. Pancreatology. 2022;22(5):564\u201371.","journal-title":"Pancreatology"},{"issue":"2","key":"2170_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s42255-022-00531-x","volume":"4","author":"M Fasolino","year":"2022","unstructured":"Fasolino M, et al. Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes. Nat Metab. 2022;4(2):284\u201399.","journal-title":"Nat Metab"},{"issue":"6","key":"2170_CR26","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41556-022-00918-8","volume":"24","author":"II Verginadis","year":"2022","unstructured":"Verginadis II, et al. A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression. Nat Cell Biol. 2022;24(6):940\u201353.","journal-title":"Nat Cell Biol"},{"key":"2170_CR27","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","volume":"18","author":"J Banchereau","year":"2000","unstructured":"Banchereau J, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767\u2013811.","journal-title":"Annu Rev Immunol"},{"issue":"13","key":"2170_CR28","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.3390\/ijms26136071","volume":"26","author":"A Alshevskaya","year":"2025","unstructured":"Alshevskaya A, et al. Molecular Signatures of Dendritic Cell Activation upon TNF Stimulation: A Multi-Omics Study in Rheumatoid Arthritis. Int J Mol Sci. 2025;26(13):6253.","journal-title":"Int J Mol Sci"},{"key":"2170_CR29","doi-asserted-by":"publisher","first-page":"p198956","DOI":"10.1155\/2012\/198956","volume":"2012","author":"M Dolcino","year":"2012","unstructured":"Dolcino M, et al. Gene expression profiling in dermatitis herpetiformis skin lesions. Clin Dev Immunol. 2012;2012:p198956.","journal-title":"Clin Dev Immunol"},{"issue":"3","key":"2170_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/MIB.0b013e31828028e8","volume":"19","author":"E Franz\u00e8","year":"2013","unstructured":"Franz\u00e8 E, et al. High expression of the A Disintegrin And Metalloprotease 19 (ADAM19), a sheddase for TNF-\u03b1 in the mucosa of patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2013;19(3):501\u201311.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02170-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02170-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02170-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T13:02:46Z","timestamp":1786453366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02170-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2170"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02170-8","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"21 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants were provided with both verbal and written information about the study and signed informed consent forms prior to participation. The study was approved by the Ethics Committee of the Second Affiliated Hospital of Fujian Medical University.(2025 Ethics Approval No. 100, The Second Affiliated Hospital of Fujian Medical University).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"172"}}